FDA Recalls High Blood Pressure Drug Hydrochlorothiazide After Mix-Up

Jack Phillips
Jack Phillips
Breaking News Reporter
|Updated:
A potentially life-threatening label mix-up prompted a recall of high blood pressure medication, said the U.S. Food and Drug Administration (FDA) on Aug. 27.
This recall is not linked to the massive FDA recall of medications containing valsartan, used for blood pressure and heart problems. A number of valsartan-containing drugs were recalled in July due to the presence of the substance NDMA, which has been linked to cancer.
Jack Phillips
Jack Phillips
Breaking News Reporter
Jack Phillips is a breaking news reporter who covers a range of topics, including politics, U.S., and health news. A father of two, Jack grew up in California's Central Valley. Follow him on X: https://twitter.com/jackphillips5
twitter
Related Topics